
Molecule ID: MOL02925
Therapeutic Area: Oncology

Synthesis Summary:
The molecule was synthesized using catalytic hydrogenation.

LCMS Results:
Observed m/z peak at 544.61 corresponding to expected molecular weight.

NMR Summary:
Proton NMR confirmed characteristic peaks between 7.0â€“8.0 ppm.

Conclusion:
The molecule meets internal analytical validation criteria and is suitable for further evaluation.
